However, as the malignancy of the tumor intensifies, the function of TGF-β shifts, promoting tumor progression and endowing cancer with more aggressive characteristics, such as EMT, tumor microenvironment remodeling, and immune system evasion by cancer cells [87]. The gene discussed is TGFB1; the disease is neoplasm.